Effect of Abhraloha tablets in anaemia
Phase 4
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2020/12/029883
- Lead Sponsor
- Shree Dhootapapeshwar Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients ready to give informed consent.
Patients of either gender between 18 to 50 years
Patients fulfilling diagnostic criteria
Exclusion Criteria
Anemia other than Iron deficiency.
K/C/O Thalassemia, Myelodysplastic syndrome, Co-exsisting infection, Inflammation etc
K/C/O serious Hepatic, Renal, Pulmonary disease, malignancy etc.
Patients receiving treatment with any other hematinic drug or multivitamins will be excluded from study.
Pregnant and Lactating Woman
Past history of hypersensitivity to any of the ingredients of study medicine.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean change in Hb %Timepoint: 2 months
- Secondary Outcome Measures
Name Time Method Safety assessed by incidence of adverse events and any abnormal laboratory parameters during the study duration.Timepoint: 2 months